• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过锚定多重PCR(阿彻融合基因检测肉瘤试剂盒)鉴定出融合肉瘤中的新型外显子-外显子断点。

Novel exon-exon breakpoint in fusion sarcoma identified by anchored multiplex PCR (Archer FusionPlex Sarcoma Panel).

作者信息

Loke Benjamin Nathanael, Lee Victor Kwan Min, Sudhanshi Jain, Wong Meng Kang, Kuick Chik Hong, Puhaindran Mark, Chang Kenneth Tou En

机构信息

Department of Biological Sciences, National University of Singapore, Singapore, Singapore.

Department of Pathology, National University Health System, Singapore, Singapore.

出版信息

J Clin Pathol. 2017 Aug;70(8):697-701. doi: 10.1136/jclinpath-2016-204247. Epub 2017 Jan 30.

DOI:10.1136/jclinpath-2016-204247
PMID:28137728
Abstract

AIMS

We describe the clinical and pathological features and novel genetic findings of a case of sarcoma occurring in the thigh of a 35-year-old man.

METHODS

Fusion gene detection using a next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) was used to identify the novel fusion breakpoints of this sarcoma using formalin-fixed and paraffin-embedded tumour material.

RESULTS

This sarcoma has a novel fusion breakpoint between exon 20 of the gene and exon 1 of the gene.

CONCLUSIONS

This case report describes an additional case of sarcoma with a novel fusion breakpoint, and demonstrates the value of this next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) in both diagnosis for patient care and in identification of a novel fusion breakpoint in this tumour type.

摘要

目的

我们描述了一名35岁男性大腿部发生的肉瘤病例的临床和病理特征以及新的基因发现。

方法

使用基于下一代测序的锚定多重PCR技术(Archer FusionPlex肉瘤检测板),对福尔马林固定石蜡包埋的肿瘤组织进行融合基因检测,以鉴定该肉瘤的新融合断点。

结果

该肉瘤在基因的第20外显子和基因的第1外显子之间有一个新的融合断点。

结论

本病例报告描述了另一例具有新融合断点的肉瘤病例,并证明了这种基于下一代测序的锚定多重PCR技术(Archer FusionPlex肉瘤检测板)在患者护理诊断以及鉴定该肿瘤类型新融合断点方面的价值。

相似文献

1
Novel exon-exon breakpoint in fusion sarcoma identified by anchored multiplex PCR (Archer FusionPlex Sarcoma Panel).通过锚定多重PCR(阿彻融合基因检测肉瘤试剂盒)鉴定出融合肉瘤中的新型外显子-外显子断点。
J Clin Pathol. 2017 Aug;70(8):697-701. doi: 10.1136/jclinpath-2016-204247. Epub 2017 Jan 30.
2
A t(4;19) pediatric undifferentiated sarcoma with a novel variant of the CIC-DUX4 fusion transcript.一例伴有新型CIC-DUX4融合转录本变异体的儿童t(4;19)未分化肉瘤
Pathol Res Pract. 2017 Mar;213(3):281-285. doi: 10.1016/j.prp.2016.12.005. Epub 2016 Dec 16.
3
The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas.CIC-DUX4 融合转录本存在于一组小儿原始小圆细胞肉瘤中。
Hum Pathol. 2012 Feb;43(2):180-9. doi: 10.1016/j.humpath.2011.04.023. Epub 2011 Aug 2.
4
Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event.小儿原始肉瘤的详细细胞遗传学和阵列分析揭示了一种复发性CIC-DUX4融合基因事件。
Cancer Genet Cytogenet. 2009 Nov;195(1):1-11. doi: 10.1016/j.cancergencyto.2009.06.015.
5
NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma.NUTM2A-CIC融合性小圆细胞肉瘤:一种CIC重排肉瘤的基因独特亚型。
Hum Pathol. 2017 Jul;65:225-230. doi: 10.1016/j.humpath.2017.01.012. Epub 2017 Feb 8.
6
Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.CIC-DUX4软组织肉瘤的靶向二代测序显示出低突变负荷和1号染色体的反复缺失。
Hum Pathol. 2016 Dec;58:161-170. doi: 10.1016/j.humpath.2016.09.004. Epub 2016 Sep 21.
7
Primary Adrenal Angiomatoid Fibrous Histiocytoma With Novel Gene Fusion Exon-Exon Breakpoint.伴有新型基因融合外显子-外显子断点的原发性肾上腺血管样纤维组织细胞瘤
Pediatr Dev Pathol. 2019 Oct;22(5):472-474. doi: 10.1177/1093526619830287. Epub 2019 Mar 1.
8
Sarcoma With CIC-DUX4 Gene Fusion: Case Report of Kidney Tumor Location in a 12-year-old Boy.伴有CIC-DUX4基因融合的肉瘤:一名12岁男孩肾脏肿瘤部位的病例报告
Pediatr Dev Pathol. 2018 Jul-Aug;21(4):406-410. doi: 10.1177/1093526617706818. Epub 2017 May 3.
9
Identification of a novel fusion transcript EWSR1-VEZF1 by anchored multiplex PCR in malignant peripheral nerve sheath tumor.通过锚定多重PCR在恶性外周神经鞘瘤中鉴定一种新型融合转录本EWSR1-VEZF1
Pathol Res Pract. 2020 Jan;216(1):152760. doi: 10.1016/j.prp.2019.152760. Epub 2019 Nov 22.
10
Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.具有 CIC 重排的浅表肉瘤是侵袭性肿瘤:一系列 8 例。
J Cutan Pathol. 2020 Jun;47(6):509-516. doi: 10.1111/cup.13656. Epub 2020 Feb 18.

引用本文的文献

1
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo.一个可递送单链和双链 Cas9/guide RNA 以在体外和体内干扰基因的平台。
Mol Ther. 2024 Oct 2;32(10):3629-3649. doi: 10.1016/j.ymthe.2024.07.025. Epub 2024 Jul 31.
2
Molecular and therapeutic advancements in Capicua ()-rearranged sarcoma.Capicua()重排肉瘤的分子与治疗进展
Front Cell Dev Biol. 2024 May 31;12:1416697. doi: 10.3389/fcell.2024.1416697. eCollection 2024.
3
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion.
FusionVAC22_01:一项I期临床试验,评估基于DNAJB1-PRKACA融合转录本的肽疫苗联合免疫检查点抑制疗法用于治疗纤维板层型肝细胞癌及其他携带致癌驱动融合的肿瘤实体。
Front Oncol. 2024 Mar 28;14:1367450. doi: 10.3389/fonc.2024.1367450. eCollection 2024.
4
Chromosome Translocation t(10;19)(q26;q13) in a CIC-sarcoma.10 号和 19 号染色体易位 t(10;19)(q26;q13)在 CIC 肉瘤中。
In Vivo. 2023 Jan-Feb;37(1):57-69. doi: 10.21873/invivo.13054.
5
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.成瘤融合蛋白 DNAJB1-PRKACA 可通过基于肽的免疫疗法在纤维板层肝细胞癌中进行特异性靶向治疗。
Nat Commun. 2022 Oct 27;13(1):6401. doi: 10.1038/s41467-022-33746-3.
6
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.全外显子组与基于锚定PCR的新一代测序相结合,显著提高了精准肿瘤学中可操作改变的检测率。
Transl Oncol. 2021 Jan;14(1):100944. doi: 10.1016/j.tranon.2020.100944. Epub 2020 Nov 12.
7
Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing.通过靶向 RNA 测序对儿科肉瘤进行遗传特征分析。
J Mol Diagn. 2020 Oct;22(10):1238-1245. doi: 10.1016/j.jmoldx.2020.07.004. Epub 2020 Aug 1.
8
Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring or Gene Fusions.恩曲替尼治疗两名患有携带NTRK或ROS1基因融合的炎性肌纤维母细胞瘤的儿科患者。
JCO Precis Oncol. 2018;2. doi: 10.1200/PO.18.00095. Epub 2018 Sep 13.
9
CIC fusion-positive sarcoma of the spermatic cord.精索 CIC 融合阳性肉瘤。
Virchows Arch. 2019 Feb;474(2):253-257. doi: 10.1007/s00428-018-2471-5. Epub 2018 Oct 11.
10
Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy.子宫内膜间质肉瘤:对其作为免疫治疗靶点潜力的重新审视。
Vaccines (Basel). 2018 Aug 25;6(3):56. doi: 10.3390/vaccines6030056.